OpenAlex
PricingAboutJobs
Log inGet started
Work

Investigational drugs in development to prevent neuromyelitis optica relapses

HTML

Year: 2018
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1080/13543784.2018.1443077
Authors: Friedemann Paul, Olwen Murphy, Santiago Pardo, Michael Levy
Institutions: Max Delbrück Center, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Johns Hopkins University
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: neuromyelitis optica spectrum disorder, relapse prevention, eculizumab, complement inhibition, IL-6 receptor inhibition, B-cell depletion, neuropathic pain, clinical trial design
SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Awards: G3584538239, Kompetenznetz Multiple Sklerose: Antikörpersignaturen als Biomarker für Diagnose, Prognose und Therapieansprechen in pathologisch definierten Subtypen der Multiplen Sklerose sowie der Neuromyelitis optica (TP Pattern MS/NMO)
OpenAlex ID: W2790969836
FWCI: 1.385
Cites: 92
Cited by: 46
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security